Barclays’s Century Therapeutics IPSC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7K | Sell |
12,197
-35,012
| -74% | -$20.1K | ﹤0.01% | 4182 |
|
|
2025
Q1 | $22K | Sell |
47,209
-23,266
| -33% | -$10.8K | ﹤0.01% | 4051 |
|
|
2024
Q4 | $71K | Buy |
70,475
+8,530
| +14% | +$8.59K | ﹤0.01% | 3867 |
|
|
2024
Q3 | $106K | Buy |
61,945
+45,797
| +284% | +$78.4K | ﹤0.01% | 3730 |
|
|
2024
Q2 | $42K | Sell |
16,148
-315
| -2% | -$819 | ﹤0.01% | 3737 |
|
|
2024
Q1 | $69K | Sell |
16,463
-15,721
| -49% | -$65.9K | ﹤0.01% | 3747 |
|
|
2023
Q4 | $107K | Buy |
32,184
+28,035
| +676% | +$93.2K | ﹤0.01% | 3701 |
|
|
2023
Q3 | $8K | Sell |
4,149
-520
| -11% | -$1K | ﹤0.01% | 4060 |
|
|
2023
Q2 | $15K | Sell |
4,669
-5,616
| -55% | -$18K | ﹤0.01% | 4011 |
|
|
2023
Q1 | $35K | Buy |
10,285
+4,877
| +90% | +$16.6K | ﹤0.01% | 3868 |
|
|
2022
Q4 | $28K | Buy |
5,408
+4,554
| +533% | +$23.6K | ﹤0.01% | 3963 |
|
|
2022
Q3 | $8K | Sell |
854
-156
| -15% | -$1.46K | ﹤0.01% | 4263 |
|
|
2022
Q2 | $8K | Sell |
1,010
-1,805
| -64% | -$14.3K | ﹤0.01% | 4384 |
|
|
2022
Q1 | $36K | Buy |
+2,815
| New | +$36K | ﹤0.01% | 4127 |
|